Publication: A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Cold Spring Harbor Laboratory Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Smedemark-Margulies, N., C. A. Brownstein, S. Vargas, S. K. Tembulkar, M. C. Towne, J. Shi, E. Gonzalez-Cuevas, et al. 2016. “A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.” Cold Spring Harbor Molecular Case Studies 2 (5): a001008. doi:10.1101/mcs.a001008. http://dx.doi.org/10.1101/mcs.a001008.
Research Data
Abstract
We describe a child with onset of command auditory hallucinations and behavioral regression at 6 yr of age in the context of longer standing selective mutism, aggression, and mild motor delays. His genetic evaluation included chromosomal microarray analysis and whole-exome sequencing. Sequencing revealed a previously unreported heterozygous de novo mutation c.385G>A in ATP1A3, predicted to result in a p.V129M amino acid change. This gene codes for a neuron-specific isoform of the catalytic α-subunit of the ATP-dependent transmembrane sodium–potassium pump. Heterozygous mutations in this gene have been reported as causing both sporadic and inherited forms of alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism. We discuss the literature on phenotypes associated with known variants in ATP1A3, examine past functional studies of the role of ATP1A3 in neuronal function, and describe a novel clinical presentation associated with mutation of this gene.
Description
Other Available Sources
Keywords
psychotic mentation
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service